Neumora Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2022 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Neumora Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2022 to Q4 2023.
  • Neumora Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 700M shares, a 42.1% decline year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 700M -510M -42.1% Dec 31, 2023 10-K 2024-03-07
Q4 2022 1.21B Dec 31, 2022 10-K 2024-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.